One in 5 patients with acute myocardial infarction (AMI) are transferred between hospitals. However, current hospital performance measures based on AMI mortality exclude these patients from the evaluation of referral hospitals.
H ospital performance on publicly reported quality measures is of increasing importance to clinicians, health care administrators, and health policy makers. Most current hospital-based performance metrics, including Centers for Medicare and Medicaid Services (CMS) metrics for patients with acute myocardial infarction (AMI), attribute outcomes for patients who undergo interhospital transfer to the transferring hospital; these patients are excluded from the performance metrics of the referral hospital that receives the patient. [1] [2] [3] As a consequence, current benchmarking approaches do not provide insight into the quality of care that a hospital provides to patients admitted in transfer, particularly given the evidence for differences in time to reperfusion 4 and mortality between directly admitted and transferred patients. 5 Understanding hospital performance for transferred patients is important because they represent up to 18% of all AMI patients, a proportion that is increasing over time. 6 Hospital performance for these patients is also important for public reporting programs, because publicly reported quality data are meant, in part, to steer transfers to high quality referral hospitals and incentivize internal quality improvement efforts. [7] [8] [9] [10] To the extent that performance is different for patients admitted natively and patients admitted in transfer, current metrics may therefore fail to provide adequate information to patients, clinicians and policy makers seeking to identify referral hospitals providing high quality tertiary care to patients with AMI. Indeed, despite early evidence that different methods of accounting for hospital transfers yields different conclusions about hospital performance rankings, 11 the choice to assign outcomes to pretransfer hospitals rather than referral hospitals remains an under-studied aspect of health policy. To better understand this issue, we examined the relationship between referral hospital performance as assessed by risk-standardized 30-day mortality for 2 groups of patients with AMI: those natively admitted to referral hospitals and those admitted to referral hospitals in transfer from another acute care hospital.
METHODS

Study Design and Data Sources
We conducted a retrospective comparative cohort study using patient-level claims data from the 2011 Medicare Provider Analysis and Review (MedPAR) file. MedPAR contains detailed demographic and billing information for individual hospitalizations for Medicare fee-for-service beneficiaries. Using unique Medicare provider identifiers, we linked patient-level data from MedPAR to hospital-level data from Medicare's Healthcare Cost Reporting Information System to obtain hospital-level characteristics.
Patients
We identified all hospitalizations for patients age 65 or older discharged between January 1, 2011 and December 31, 2011 with a principal diagnosis of AMI using previously validated International Classification of Diseases, Ninth Edition, Clinical Modification diagnosis codes. 1 Among these hospitalizations we defined interhospital transfers as instances when a patient was discharged from one hospital on a given day and admitted to a different hospital on the same day or the subsequent day, and for which both hospitalizations were for AMI, as previously performed. 12, 13 We defined "natively admitted" patients as those that were not admitted in transfer from another institution. These patients are currently the subject of existing CMS performance measures. We defined "admitted in transfer" patients as those admitted in transfer from another institution. These patients are currently excluded from existing CMS performance measures in the evaluation of referral hospitals.
We included only short-stay hospitals, which could either be general hospitals or specialty hospitals, because short-stay cardiology specialty hospitals were likely to care for a significant number of patients transferred with AMI. We excluded hospitals with fewer than 15 hospitalizations for patients admitted in transfer, in order to restrict our analysis to the referral hospitals for which this research question primarily applies and to reduce random variation from unreliably small sample sizes. In practice this also restricted our analysis to those hospitals with at least 15 natively admitted patients, as there were not any hospitals with more than 15 transferred patients and fewer than 15 natively admitted patients. In the event of multiple episodes of care for a given patient, we selected the first episode, to reduce the influence of observed prior hospitalizations for AMI on the transfer decisions and outcomes, and to maintain independence of observations. We included only the claims at posttransfer destination hospitals, excluding claims for pretransfer stays at outside hospitals, because our analysis is focused on outcomes of patients at referral hospitals.
Variables
The primary outcome variable was hospital-specific risk-standardized 30-day mortality from the date of hospital admission. We obtained death dates from the Medicare Beneficiary Summary File. To control for variation in baseline risk we designed a risk-adjustment strategy analogous to that used in the current CMS performance measure for AMI mortality; the primary difference is that we did not have access to outpatient data and therefore used Elixhauser comorbidities from inpatient claims rather than the hierarchical condition category schema. Variables for riskadjustment included age, sex, comorbidities in the manner of Elixhauser, 14 history of prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), presence of anterior MI, and presence of inferolateral or posterior MI. 1 
Analysis
Descriptive Analyses
To characterize the cohort, we examined demographic and clinical characteristics for the 2 groups of patients: those natively admitted to a referral hospital, and those admitted in transfer. We did not test significance of differences in demographic or clinical characteristics, because the size of the cohort was likely to indicate statistical significance even for small but clinically nonmeaningful differences. We calculated the median and interquartile range of the absolute number and proportion of patients admitted in transfer.
Calculating Hospital-specific Risk-adjusted Mortality Rates
We used hierarchical logistical regression to generate hospital-specific risk-standardized 30-day mortality rates (RSMR). The RSMR is the ratio of predicted to expected mortality and is both risk and reliability adjusted. In lowervolume hospitals, where small changes in the absolute number of patients can create instability in the absolute mortality estimates, the RSMR "shrinks" the mortality rate toward the population mean. Conversely, for hospitals with large numbers of patients and for which performance estimates are more reliable, the RSMR approximates conventional risk-adjusted mortality rates. This approach is common in the current benchmarking literature and is identical to the approach CMS uses in its hospital pay-forperformance programs. 1, 12, 13 To generate hospital-specific RSMRs, we fit a randomeffects logistic regression model (Eq. 1) for patient i in hospital j, in which the dependent variable Y ij was 30-day mortality, and the independent variables x 1 À x n were age (as quadratic splines), sex, comorbidities (as indicator covariates), history of PCI, history of CABG, location of MI (as indicator covariates). To estimate SE, we used bootstrapping with replacement to account for patient clustering at the hospital level. 15 logitðY
ðEquation 1Þ In this model, b 1 À b n are the coefficients for the independent variables, m the mean intercept across all patients, and o j the hospital-specific random intercept term, which accounts for clustering of patients at the hospital level. We calculated expected probability of mortality for patients within each hospital by using the mean value across all hospitals as the common intercept (m). Thus, the expected mortality rate is the number of deaths expected if patients with the same characteristics were treated at a "reference" hospital. Next, we calculated predicted probability of mortality for patients within each hospital by estimating the hospital-specific mean from the random intercept model (m+o j ). Thus, the predicted mortality rate is based upon observed patient characteristics and estimated hospital-level random effects. Finally, we calculated RSMRs for each hospital as the ratio of predicted to expected mortality multiplied by the national average for the cohort. We performed this analysis separately for natively admitted patients and those admitted in transfer, yielding 2 unique RSMRs for each hospital. We evaluated the discriminative power of the models using the area under the receiver-operator curve.
Comparing Performance Assessment Across Patient Groups
To determine the degree to which RSMR for natively admitted patients is associated with RSMR for transferred patients, and thus provides similar information regarding hospital performance, we assessed both the correlation in RSMRs and agreement in hospital rankings by RSMR. We used the Pearson correlation coefficient to assess the linear relationship between RSMR for natively admitted patients and RSMR for transferred patients. We categorized hospitals by quartile for RSMR for the 2 groups of patients and determined the number of hospitals that moved up or down at least 2 quartiles between the groups. These hospitals were therefore in the top quartile of performance for one group and below the median for the other, or in the bottom quartile of performance for one group and above the median for the other group. We also assessed the agreement in ranking using a standard weighted k statistic to account for multiple quartiles.
Characteristics of Hospitals With Concordant and Discordant Performance
We next examined characteristics of hospitals with similar performance for patients admitted in transfer and natively admitted patients, in comparison with those hospitals with discordant performance across the 2 groups of patients. We defined hospitals with "discordant performance" as those that moved up or down at least 2 performance quartiles between natively admitted patients and those admitted in transfer. We considered separately those hospitals with comparatively higher performance for natively admitted patients and those hospitals with comparatively higher performance for patients admitted in transfer. We defined hospitals with "similar performance" across the patient groups as all others-that is, those hospitals in the same performance quartile, as well as those that moved up or down only a single quartile of performance. We obtained hospital characteristics from Healthcare Cost Reporting Information System, including total beds and hospital metropolitan statistical area size-as well as MedPAR, including the number of AMI hospitalizations per hospital and the number of AMI patients undergoing PCI and CABG. We compared these hospital characteristics across the 3 hospital groups using the Kruskal-Wallis testing for nonparametric distributions, adjusted for multiple comparisons.
Sensitivity Analysis
We conducted a sensitivity analysis in which we calculated the RSMR for transferred patients adjusting for the length of stay in the transferring hospital prior to transfer, because a delay in transfer and definitive management can influence outcomes for patients with AMI, 16 and it is possible that patients with varying duration of pretransfer hospitalization represented fundamentally different patient populations.
We performed all analyses using SAS version 9.0 (Carey, NC) and STATA version 14.0 (College Station, TX). The use of deidentified patient-data for this study was reviewed and approved by the University of Pittsburgh Office of Human Research Protections (PRO11070007).
RESULTS
Patient and Hospital Selection and Characteristics
Of 4207 hospitals, 304 (7.2%) had at least 15 patients natively admitted and admitted in transfer and were included in the primary analysis. Within these hospitals, there were 77,711 natively admitted patients [median per hospital, 232; interquartile range (IQR), 162-321], and 11,829 patients admitted in transfer (median per hospital, 26; IQR, 19-46). The cohort selection flow diagram is depicted in Figure 1 . There was variation among included hospitals in both the volume and the proportion of AMI patients who were natively admitted versus admitted in transfer (median proportion of patients admitted in transfer 11.0%, IQR, 7.9%-17.2%).
Characteristics of natively admitted and transferred patients are shown in Table 1 . In comparison with natively admitted patients, patients admitted in transfer had a similar age and sex distribution. Transferred patients were more likely to have a history of prior PCI (6.1% vs. 3.2%) and to undergo CABG surgery (21.6% vs. 10.2%). Rates of PCI during admission were similar (47.5% vs. 46.3%). Transferred patients were less likely to have an anterior MI (5.0% vs. 9.7%) or to require intensive care unit admission (71.6% vs. 75.3%), and had a lower unadjusted 30-day mortality rate (7.2% vs. 11.5%).
Comparison of Hospital Performance
Our risk-adjustment models had good discriminative power, with c-statistics of 0.74 for natively admitted patients and 0.72 for patients admitted in transfer. On the basis of these models there was a statistically significant but weak correlation between hospital RSMRs for natively admitted patients and those admitted in transfer (Pearson r = 0.24, P < 0.001, Fig. 2 ). Of the 304 hospitals included in the analysis, 102 (33.6%) moved up or down at least 2 quartiles of performance, and 30 hospitals (9.9%) moved 3 performance quartiles across the 2 groups of patients. The complete distribution of performance quartiles and changes is shown in Table 2 . Overall, there was very poor agreement for hospital ranking by RSMR for natively admitted and transferred patients (weighted k = 0.09, P = 0.01).
Examination of Hospitals With Discordant Performance
Of the 102 hospitals moving at least 2 quartiles of performance, 50 hospitals (16.4% of the total number of hospitals) had comparatively lower ranks for natively admitted patients and 52 hospitals (17.1%) had comparatively lower ranks for patients admitted in transfer. We categorized the 202 remaining hospitals as having similar performance for the 2 patient groups. Hospitals with similar performance across natively admitted and transferred patients were slightly larger and cared for more AMI patients than those with discordant performance. There were no other major differences between groups, nor were any of the differences statistically significant when adjusted for multiple comparisons (Table 3) .
Sensitivity Analysis
When we included length of stay at the transferring hospital as a covariate, the results did not change. There remained a statistically significant but weak association between hospital RSMRs for natively admitted patients and those admitted in transfer (Pearson r = 0.25, P < 0.0001). There were again 50 hospitals with comparatively lower ranks for natively admitted patients and 52 hospitals with comparatively lower ranks for patients admitted in transfer.
DISCUSSION
In a national study of elderly patients with AMI we found little correlation between risk-standardized mortality for natively admitted patients and risk-standardized mortality for patients admitted in transfer. In addition, there was very poor agreement in hospital ranking by RSMR for these 2 patient groups-hospitals that had relatively low riskstandardized mortality for one group of patients often had relatively high risk-standardized mortality for the other group of patients. These findings suggest that the current practice of attributing outcomes for patients admitted in transfer to the transferring, rather than referral hospital, results in performance assessments that do not provide insight about the quality of care for patients after interhospital transfer for AMI.
Our results suggest that the domains of quality differ between transferred and natively admitted AMI patients. It is likely that natively admitted patients benefit primarily from speedy reperfusion and early administration of b-blockade [16] [17] [18] [19] ; while transferred patients benefit primarily from prevention of iatrogenic injury (such as infections) and late postoperative complications. [20] [21] [22] There is not a reason that these different domains of quality necessarily track together, potentially leading to the finding of discordant performance for natively admitted patients and those admitted in transfer. Indeed, prior research in other fields demonstrates disparate performance by the same providers caring for different groups of patients. 23, 24 Quality measurement and performance benchmarking are integral to value-based purchasing and other quality-focused health policies, [25] [26] [27] [28] [29] underscoring the importance of accounting for the impact of interhospital transfers on hospital performance. Our results also highlight potential flaws in quality improvement programs that depend on accurate performance assessment. At the local level, clinicians at a tertiary care hospital with low AMI mortality based on national benchmarking data may not be aware that their hospital has worsethan-expected outcomes for patients admitted in transfer, and therefore fail to implement changes targeting that patient population. Alternatively, hospital-wide efforts to improve outcomes for natively admitted patients may be inefficient or inappropriate when outcomes for transferred patients are relatively good. At the regional level, efforts to transfer patients to the best referral hospitals cannot succeed without accurate data on the outcomes of transferred patients at tertiary facilities. Indeed, despite evidence that interhospital transfer may be beneficial for individual patients, 5, 30 there does not appear to be any relationship between increased transfers and patient outcomes at the hospital level across the US health care system. 12 At the same time, hospitals without procedural capabilities do not consistently transfer patients to the nearest high-performing procedure hospital, highlighting an opportunity to improve triage and transfer practices. 13 Accurately measuring and effectively improving outcomes for patients undergoing interhospital transfer are increasingly important health policy priorities. Nearly 20% of patients with AMI undergo interhospital transfer, and this proportion is increasing over time. 6 As hospital systems become more centralized through the implementation of regional systems of care, 31 it is likely that interhospital transfer will be increasingly common for patients with AMI and other medical conditions. AMI mortality is a component of Medicare's value-based purchasing program, meaning that the current approach to outcome attribution affects not only measurement and clinical care but also hospital finances. 29 Thus, it is critical that we create quality measures that provide accurate information regarding quality of care for this group of transferred patients.
Designing quality measures that accurately and fairly account for quality of care surrounding interhospital transfer will require careful consideration of the impact of modeling decisions. One approach would involve using marginal structural models to treat hospital quality as a time-varying covariate, 32, 33 apportioning the influence of hospital quality on patient outcomes based on the time of treatment relative to the outcome. In this case, a hospital that delivers highquality care would not be punished for the impact of lower quality care at downstream facilities. However, such an approach could also "adjust away" the decision of one hospital to transfer patients to a lower-quality tertiary care hospital, when in fact we may want to incentivize transfers to higher quality hospitals. An approach to hospital benchmarking that accounts for variation in quality across multiple care settings will therefore require both complex statistical models and thoughtful consideration of their policy implications.
Our finding of substantial variation in the proportion of transferred patients at referral hospitals, in concert with existing data on variation in transfer rates at nonprocedure hospitals, 13 also raises questions regarding the potential impact of the many complex incentives surrounding interhospital transfer decisions. Insurance considerations, hospital networks, the impact of transfers on hospital benchmarking, and incentives for patients and physicians may influence both the decision to transfer a patient and the ultimate transfer destination. 34, 35 Future studies should explore how these incentives surrounding interhospital transfer influence transfer destination, clinical outcomes, and quality measurement.
Our work has several limitations. First, as with all analyses of administrative claims data, our models lack granular clinical information on severity of illness, which may limit their discriminative capabilities. In addition, we did not have access to outpatient data and therefore used Elixhauser comorbidities from inpatient claims rather than hierarchical condition categories as in the CMS models. However, our models had discriminative performance equal to those used by CMS in its AMI hospital profiling program, increasing the face validity of our findings. 1 Importantly, although administrative coding may vary across hospitals, it is unlikely to vary within a given hospital for natively admitted and transferred patients, so coding practices are unlikely to explain our findings. Similarly, the administrative data lack information on stability of the patient at the time of transfer, quality of care during medical transport, and other patient factors that could influence clinical outcomes. Second, because our analysis was limited to Medicare fee-forservice beneficiaries, the findings may not generalize to younger patients or those with Medicare Advantage insurance plans. Third, because AMI care pathways involve revascularization procedures, our findings may not extrapolate to hospital benchmarking for other conditions that are less dependent upon specific procedures or services that may trigger the decision to transfer a patient. Fourth, the fact that hospitals with concordant performance cared for higher volumes of transferred patients could be related to greater stability of the statistical estimates for mortality at highervolume hospitals. However, given the significant overlap in patient volumes in hospitals with discordant and concordant performance, reflecting the fact that even higher-volume hospitals can have discordant performance, our findings are unlikely to represent a purely statistical phenomenon. Finally, only a relatively small proportion of hospitals care for significant numbers of transferred patients and were therefore included in our analysis. Nevertheless, these are large, tertiary hospitals that care for a disproportionate number of overall patients with AMI, including nearly 3 quarters of AMI transfers in our cohort, increasing the importance of accurately assessing their performance.
CONCLUSIONS
Hospital-specific risk-standardized mortality for natively admitted patients with AMI is only weakly associated with hospital-specific risk-standardized mortality for patients with AMI admitted in transfer from another hospital. Future research is needed explore the mechanism underlying these findings, including contributions from quality of care before and during transfer, and to develop novel performance metrics that simultaneously provide both a more comprehensive assessment of patient outcomes throughout an episode of care and a more granular evaluation of outcomes for different groups of patients at centers caring for a significant number of patients transferred from other hospitals. Hospitals with similar performance across groups were those in the same performance quartile and those that moved up or down only one performance quartile across groups. Hospitals comparatively better for natively admitted patients improved two performance quartiles relative to performance for patients admitted in transfer. Hospitals comparatively better for patients admitted in transfer improved 2 performance quartiles relative to performance for natively admitted patients.
AMI indicates acute myocardial infarction; CABG, coronary artery bypass grafting; IQR, interquartile range; MSA, metropolitan statistical area; PCI, percutaneous coronary intervention.
